From David Buswell, CEO Immune Response BioPharma
GOTO HELL
From: Joel Reese
Sent: Tuesday, June 18, 2013 1:57 PM
To: David Buswell
Subject: Investment with Immune Response BioPharma
Sent: Tuesday, June 18, 2013 1:57 PM
To: David Buswell
Subject: Investment with Immune Response BioPharma
Dear Mr. Buswell:
I am very impressed with the description of Immune Response BioPharma on your company's website. It seems you have a number of drugs in development any one of which would be of great benefit to those who suffer from these terrible diseases. If just one of these drugs should gain approval Immune Response BioPharma could become profitable in a very short time.
I am also aware that your company is attempting to use research from the Immune Response/Orchestra Corporation in an attempt to raise funding for Immune Response BioPharma. As a long time investor in IMNR/OCHT still holding 64,483 shares I wish to advise you that the research was not abandoned by its investors and I feel that illegal manipulation of the IMNR/OCHT stock and ownership was used to basically steal its research and cheat its creditors in an attempt to create what you now call Immune Response Biophama.
Your company boasts a great deal of what the legality of what it is doing, but I say to you that it is immoral, unfair, and unwise to simply abandon the stock holders who financed the research you now claim to own without offering to make their stock holdings now part of the new company or offering them fair payment for their stock.
I don't know what if anything the owners of IMNR/OCHT stock can do at this point legally to protect their rights, but I can assure you that I will make every effort to see that I am not cheated and to let other potential investors of yours know of your company's history and connection to IMNR/OCHT to prevent what happened to us from happening to them.
There is such a thing as right and wrong and what you are attempting to do is clearly wrong.
I am writing to inquire if Kevin Kimberlin who purchased property rights to research at IMNR/OCHT through Spencer Trask is involved in the Immune Response BioPharma Corporation and what his role is? I am sure that Spencer Trask, David Buswell, and Immune Response BioPharma wish to be honorable in how they handle this and treat the investors of IMNR fairly.
Thank you for your consideration and assistance.
|
